Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Metagenomic Sequencing Market From 2025 To 2029?

The rapid expansion of the metagenomic sequencing market in recent years has been noteworthy, with projections suggesting its size increasing from $2.13 billion in 2024 to $2.5 billion in 2025. The impressive compound annual growth rate (CAGR) is estimated at 17.5%. The historical growth of this market segment can be associated with several factors such as increased government involvement, an increase in the number of metagenome sequencing research initiatives, the rising application of metagenomics in genomics and diagnostic research, the provision of funding for research, and the advancement of Next-Generation Sequencing (NGS) data analysis tools.

What Is the Projected Market Size of the Metagenomic Sequencing Market?

In the ensuing years, a significant expansion is projected for the metagenomic sequencing market, with its value expected to reach $4.71 billion by 2029, representing a compound annual growth rate (CAGR) of 17.1%. Factors thought to be driving this future growth encompass a decline in computational costs, a heightened emphasis on identifying new beneficial biomolecules, an increased adoption of high-capacity sequencing technologies, a growing demand for personalised medicine, and disease diagnosis, combined with prevalence surge of infectious diseases. Big trends for the said forecast period comprise trailblazing technologies, the use of modern genomic technology in metagenomics, escalated R&D budgets, advancements in the sequencing tech industry, and the application of big data to NGS data analysis.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp

Who are the Major Competitors in the Metagenomic Sequencing Market Outlook?

Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH

What Is Fueling Growth in the Metagenomic Sequencing Market?

The rise in infectious diseases occurrences is anticipated to catalyze the expansion of the metagenomic sequencing market. These diseases are brought on by harmful microbes like bacteria, viruses, parasites, or fungi that can be transferred directly or indirectly between people. The mounting incidence of illnesses that compromise the immune system, including HIV/AIDS, cancer treatments, and autoimmune disorders, raises individuals’ vulnerability to such infectious diseases. Metagenomic sequencing offers a robust, adaptable means for researching these diseases, giving key insights into the diversity of pathogens, transmission patterns, antimicrobial resistance, and surveillance of outbreaks. In January 2023, a report by the Government of Canada, a federal authority based in Canada, revealed that 135 and 159 rabies samples were submitted in October and November 2022 respectively. Moreover, in March 2023, based on data from the U.S. government agency, the Centers for Disease Control and Prevention, tuberculosis (TB) cases in the US experienced a 5.9% rise from 7,874 cases in 2021 to 8,331 in 2022. Consequently, the uptick in infectious diseases occurrences is propelling the growth of the metagenomic sequencing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16117&type=smp

Which Metagenomic Sequencing Market Segments Are Growing the Fastest?

The metagenomic sequencing market covered in this report is segmented –

1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions

2) By Technology: 16S Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics

3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications

Subsegments:

1) By Reagents And Consumables: DNA Or RNA Extraction Kits, Library Preparation Kits, Sequencing Kits, PCR And qPCR Reagents, Other Consumables (Buffers, Probes)

2) By Instruments: Next-Generation Sequencers (NGS), Third-Party Sequencers, Microarrays, Real-Time PCR Instruments

3) By Sequencing Services: Whole Genome Sequencing (WGS), 16S rRNA Sequencing, Shotgun Metagenomic Sequencing, Amplicon Sequencing, Metatranscriptomic Sequencing

4) By Analysis And Data Interpretation Solutions: Bioinformatics Software, Cloud-Based Data Analysis Services, Data Storage Solutions, Custom Analysis Tools, Data Interpretation Platforms

Which Industry Trends Are Shaping the Future of the Metagenomic Sequencing Market?

The leading businesses in the metagenomic sequencing market are prioritizing innovation in sequencing services to enhance precision, throughput, and cost-effectiveness. These services employ state-of-the-art genomic technologies that allow for sequencing of larger DNA fragments, offering a more extensive understanding of genetic structures compared to traditional short-read techniques. For example, Clinical Microbiomics A/S, a biotechnology firm based in Denmark, unveiled superior long-read sequencing services in April 2024. These services, including 16S, ITS, 18S rRNA, custom gene sequencing, and comprehensive genomics and metagenomics, deliver unmatched resolution and quality in microbial analysis. This enables a deeper understanding of microbial communities and supports the generation of superior quality metagenome-assembled genomes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Which Countries Are Leading the Metagenomic Sequencing Market?

North America was the largest region in the metagenomic sequencing market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16117

This Report Delivers Insight On:

1. How big is the metagenomic sequencing market, and how is it changing globally?

2. Who are the major companies in the metagenomic sequencing market, and how are they performing?

3. What are the key opportunities and risks in the metagenomic sequencing market right now?

4. Which products or customer segments are growing the most in the metagenomic sequencing market?

5. What factors are helping or slowing down the growth of the metagenomic sequencing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model